Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	6.79	-22.46	-24.10
Graham Fair Price	0.00	1.17	1.17
PEG	inf	0.00	-0.10
Price/Book	-5.68	1.49	1.58
Price/Cash Flow	5.68	-76.64	-81.26
Prices/Earnings	5.68	-5.94	-6.30
Price/Sales	-5.68	43.44	46.06
Price/FCF	5.68	-76.64	-81.26
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.71	0.71
Operating Margin	0.00	-1.40	-1.40
ROA	0.00	-0.06	-0.06
ROE	-0.06	-0.06	0.00
ROIC	-0.05	-0.05	1.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.68	-0.49	38.02
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.25	0.00	inf
EPS QOQ	-0.63	0.00	inf
FCF QOQ	0.37	0.00	inf
Revenue QOQ	-0.09	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	475.99	475.99	0.00
Days Sales Outstanding (DSO)	113.78	113.78	0.00
Inventory Turnover	0.19	0.19	0.00
Debt/Capitalization	0.02	0.03	66.16
Quick Ratio	9.69	6.07	-37.34
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.99	0.99	0.00
Cash	0.75	0.45	-39.46
Capex	< 0.005	< 0.005	0.00
Free Cash Flow	-0.02	-0.02	0.00
Revenue	0.03	0.03	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	10.55	10.55	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.28	9.02	-2.79
Naive Interpretation	Member

06 - Financial Health · Bad

Rating